| Kolb, Noah Allan |
University Of Vermont & St Agric College
United States |
Remote Monitoring of Management of Chemotherapy induced Peripheral Neuropathy |
5R01CA247517-05 |
|
Brennan Streck, Ph.D., RN, M.P.H. |
| Kong, Mei |
University Of California-Irvine
United States |
Using dietary glutamine supplementation for melanoma prevention and targeted therapy |
5R01CA244360-05 |
PA-20-185 (Parent R01 Clinical Trial Not Allowed) |
Gabriela Riscuta, M.D., CNS |
| Kooperberg, Charles L |
Fred Hutchinson Cancer Center
United States |
Statistics and Data Management Center (SDMC) for the NCI Cancer Screening Research Network (CSRN) |
5UG1CA287013-02 |
|
Elyse LeeVan, M.D., M.P.H. |
| Kresty, Laura A |
University Of Michigan At Ann Arbor
United States |
Developing Natural Products to Target IL-8 Signaling and Intercept Progression of Barrett’s Esophagus to Esophageal Adenocarcinoma |
1UG3CA299397-01 |
|
Altaf Mohammed, Ph.D. |
| Krist, Alexander H |
Virginia Commonwealth University
United States |
Virginia Cancer Screening Research Network Access Hub (Virginia CSRN Hub) |
3UG1CA287017-02S1 |
|
Elyse LeeVan, M.D., M.P.H. |
| Kroetz, Deanna L |
Ohio State University
United States |
Sphingolipid Signaling and Chemotherapy-Induced Peripheral Neurotoxicity |
5R01CA261068-06 |
|
Rachel Altshuler, Ph.D. |
| Kuhn, Peter |
University Of Southern California
United States |
Multi-modal Liquid Biopsy Early Assessment of Breast Cancer, Pancreatic Cancer, and Multiple Myeloma |
5U01CA285013-02 |
|
|
| Kumar, Nagi B. |
H. Lee Moffitt Cancer Ctr & Res Inst
United States |
Phase II Clinical trial of GTC in Men on Active Surveillance |
5R01CA235032-06 |
|
Howard L. Parnes, M.D. |
| Labaer, Joshua |
Arizona State University-Tempe Campus
United States |
High-throughput immunoproteomics for cancer biomarker discovery |
5U2CCA271903-03 |
|
Christos Patriotis, Ph.D., M.Sc. |
| Labaer, Joshua |
Arizona State University-Tempe Campus
United States |
Multiplex In-Solution Protein Array (MISPA) for high throughput, quantitative, early profiling of pathogen-induced head and neck |
5R33CA281802-02 |
|
Wendy Wang, Ph.D., M.Sc. |
